ABT vs. PODD: Abbott Laboratories vs. Insulet Stock Comparison
How do Abbott Laboratories (ABT) and Insulet (PODD) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Abbott Laboratories (ABT) and Insulet (PODD) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.
| Profile Item | ABT | PODD |
|---|---|---|
| Name | Abbott Laboratories | Insulet Corporation |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Equipment | Health Care Equipment |
| Market Capitalization | 190.39 billion USD | 10.16 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | Nasdaq |
| Listing Date | March 17, 1980 | May 15, 2007 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | ABT | PODD |
|---|---|---|
| Total Return (1Y) | -10.78% | -53.25% |
| Total Return (3Y, Annualized) | 7.79% | -0.74% |
| Total Return (5Y, Annualized) | -0.79% | -14.02% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | ABT | PODD |
|---|---|---|
| Volatility (1Y, Annualized) | 28.48% | 46.33% |
| Beta (5Y) | 0.53 | 1.04 |
| Max Drawdown (5Y) | -39.64% | -63.02% |
| Avg. Volume (3M) | 8.74M | 1.58M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | ABT | PODD |
|---|---|---|
| Sharpe Ratio (1Y) | -0.53 | -1.24 |
| Sortino Ratio (1Y) | -0.76 | -1.51 |
Profitability
ROE (TTM)
Insulet (PODD) at 28.94% sits in the top ROE quartile, while Abbott Laboratories (ABT) at 9.14% is closer to the peer norm — stronger capital efficiency for PODD.
ABT
Health Care Equipment & Services industry group
9.14%
- Max
- 47.61%
- Q3
- 14.36%
- ABT
- 9.14%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
PODD
Health Care Equipment & Services industry group
28.94%
- Max
- 47.61%
- PODD
- 28.94%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
For every dollar of sales, both Abbott Laboratories (ABT) at 9.75% and Insulet (PODD) at 13.44% retain more as net profit than most peers, landing in the top net margin quartile of their industries.
ABT
Health Care Equipment & Services industry group
9.75%
- Max
- 29.35%
- ABT
- 9.75%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
PODD
Health Care Equipment & Services industry group
13.44%
- Max
- 29.35%
- PODD
- 13.44%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Insulet (PODD) at 22.54% operates in the top operating margin quartile, ahead of Abbott Laboratories (ABT) at 11.66%, which runs around its industry’s norm.
ABT
Health Care Equipment & Services industry group
11.66%
- Max
- 35.43%
- Q3
- 14.14%
- ABT
- 11.66%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
PODD
Health Care Equipment & Services industry group
22.54%
- Max
- 35.43%
- PODD
- 22.54%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | ABT | PODD |
|---|---|---|
| ROE (TTM) | 9.14% | 28.94% |
| ROA (TTM) | 4.90% | 11.40% |
| Net Margin (TTM) | 9.75% | 13.44% |
| Operating Margin (TTM) | 11.66% | 22.54% |
| Gross Margin (TTM) | 57.17% | 71.88% |
Growth
Revenue Growth
Insulet (PODD) at 30.73% sits in the top revenue growth quartile, while Abbott Laboratories (ABT) at 5.67% is closer to the peer norm — faster top-line expansion for PODD.
EPS Growth
Both Abbott Laboratories (ABT) at -51.31% and Insulet (PODD) at -39.79% post bottom-quartile EPS growth versus peers, pointing to weaker earnings momentum than typical rivals.
Growth Metrics
| Metric | ABT | PODD |
|---|---|---|
| Revenue Growth (YoY) | 5.67% | 30.73% |
| Revenue Growth (3Y CAGR) | 0.51% | 27.54% |
| EPS Growth (YoY) | -51.31% | -39.79% |
| EPS Growth (3Y CAGR) | -1.65% | 267.70% |
Financial Strength
Current Ratio (MRQ)
Both Abbott Laboratories (ABT) at 1.46 and Insulet (PODD) at 2.51 carry current ratio within their industries’ typical mid-ranges, suggesting balanced short-term liquidity relative to peers.
ABT
Health Care Equipment & Services industry group
1.46
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- ABT
- 1.46
- Q1
- 1.37
- Min
- 0.30
PODD
Health Care Equipment & Services industry group
2.51
- Max
- 7.59
- Q3
- 4.00
- PODD
- 2.51
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Both Abbott Laboratories (ABT) at 0.61 and Insulet (PODD) at 0.66 fund their balance sheets with roughly industry-typical debt-to-equity mixes.
ABT
Health Care Equipment & Services industry group
0.61
- Max
- 1.88
- Q3
- 0.91
- ABT
- 0.61
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
PODD
Health Care Equipment & Services industry group
0.66
- Max
- 1.88
- Q3
- 0.91
- PODD
- 0.66
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | ABT | PODD |
|---|---|---|
| Current Ratio (MRQ) | 1.46 | 2.51 |
| Debt / Equity (MRQ) | 0.61 | 0.66 |
| Net Debt / EBITDA | 2.37 | 0.65 |
Dividends
Dividend Yield (TTM)
Insulet (PODD) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Abbott Laboratories (ABT) reports a yield of 2.22%, ranking against industry peers normally.
ABT
Health Care Equipment & Services industry group
2.22%
- ABT
- 2.22%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
PODD
Health Care Equipment & Services industry group
0.00%
- PODD
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Insulet (PODD) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Abbott Laboratories (ABT) reports a payout of 92.54%, ranking against industry peers normally.
ABT
Health Care Equipment & Services industry group
92.54%
- ABT
- 92.54%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
PODD
Health Care Equipment & Services industry group
0.00%
- PODD
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | ABT | PODD |
|---|---|---|
| Dividend Yield (TTM) | 2.22% | 0.00% |
| Dividend Payout Ratio (TTM) | 92.54% | 0.00% |
Valuation
P/E Ratio (TTM)
Both Abbott Laboratories (ABT) at 41.02 and Insulet (PODD) at 23.94 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.
ABT
Health Care Equipment & Services industry group
41.02
- Max
- 80.41
- Q3
- 47.62
- ABT
- 41.02
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
PODD
Health Care Equipment & Services industry group
23.94
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- PODD
- 23.94
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
On P/S ratio, both Abbott Laboratories (ABT) at 3.95 and Insulet (PODD) at 3.19 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.
ABT
Health Care Equipment & Services industry group
3.95
- Max
- 8.80
- Q3
- 4.32
- ABT
- 3.95
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
PODD
Health Care Equipment & Services industry group
3.19
- Max
- 8.80
- Q3
- 4.32
- PODD
- 3.19
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
Abbott Laboratories (ABT) at 3.73 is valued about in line with its industry on P/B ratio, while Insulet (PODD) at 6.44 carries an above-peer premium to book — PODD is pricier on assets.
ABT
Health Care Equipment & Services industry group
3.73
- Max
- 11.68
- Q3
- 6.12
- ABT
- 3.73
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
PODD
Health Care Equipment & Services industry group
6.44
- Max
- 11.68
- PODD
- 6.44
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | ABT | PODD |
|---|---|---|
| P/E Ratio (TTM) | 41.02 | 23.94 |
| P/S Ratio (TTM) | 3.95 | 3.19 |
| P/B Ratio (MRQ) | 3.73 | 6.44 |
| Free Cash Flow Yield (TTM) | 3.19% | 1.12% |